The NIBRT GlycoScience Group is a world leading group in the application of UPLC, HPLC, CE and MS technologies for glycan analysis and exoglycosidase sequencing of site-specific glycosylation. Our technology provides a service that supports the drug development pipeline of leading pharmaceutical companies, as well as underpinning our diverse research programme.
NIBRT is funded by the IDA Ireland with a mandate to support the development of the existing bioprocessing industry in Ireland and to attract additional bioprocessing companies to Ireland.
The GlycoScience group’s research is funded by a wide variety of academic and industrial collaborations and grants:
Key Research Areas in the GlycoScience Group.
- Glycobiomarker discovery and method development
- Biotherapeutic characterisation (HPLC, UPLC, CE and MS)
- High-throughput glycan analysis.
- Investigating the role of glycosylation in disease
- Glycan Bioinformatics